Bicara Therapeutics logo

Bicara Therapeutics Share Price Today

(NASDAQ: BCAX)

Bicara Therapeutics share price is $14.88 & ₹1,294.10 as on 6 Mar 2025, 2.30 'hrs' IST

$14.88

1.21

(8.85%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Bicara Therapeutics share price in Dollar and Rupees. Guide to invest in Bicara Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bicara Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Bicara Therapeutics share price movements

  • Today's Low: $12.81
    Today's High: $14.88

    Day's Volatility :13.91%

  • 52 Weeks Low: $11.10
    52 Weeks High: $28.09

    52 Weeks Volatility :60.48%

Bicara Therapeutics (BCAX) Returns

PeriodBicara TherapeuticsIndex (Russel 2000)
3 Months
-23.85%
0.0%
6 Months
-36.44%
0.0%
1 Year
-36.44%
0.0%
3 Years
-36.44%
-11.6%

Bicara Therapeutics (BCAX) Key Statistics

in dollars & INR

Previous Close
$13.67
Open
$13.8
Today's High
$14.88
Today's Low
$12.81
Market Capitalization
$1.1B
Today's Volume
$340.6K
52 Week High
$28.09
52 Week Low
$11.1
Revenue TTM
$0.0
EBITDA
$-58.3M
Earnings Per Share (EPS)
$-3.75
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Bicara Therapeutics Stock (BCAX) from India?

It is very easy for Indian residents to invest directly in Bicara Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bicara Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bicara Therapeutics or BCAX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bicara Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bicara Therapeutics shares which would translate to 0.058 fractional shares of Bicara Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bicara Therapeutics, in just a few clicks!

Returns in Bicara Therapeutics (BCAX) for Indian investors in Rupees

The Bicara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bicara Therapeutics investment value today

Current value as on today

₹68,511

Returns

₹31,489

(-31.49%)

Returns from Bicara Therapeutics Stock

₹36,437 (-36.44%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Bicara Therapeutics (BCAX)

-36%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Bicara Therapeutics Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Bicara Therapeutics

Insights on Bicara Therapeutics Stock (Ticker Symbol: BCAX)

  • Price Movement

    In the last 7 days, BCAX stock has moved up by 20.4%

Bicara Therapeutics Technicals Summary

Sell

Neutral

Buy

Bicara Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Bicara Therapeutics (BCAX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bicara Therapeutics logo
21.57%
-36.44%
-36.44%
-36.44%
-36.44%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bicara Therapeutics logo
NA
NA
NA
0.0
0.0
0.0
NA
-5.1
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bicara Therapeutics logo
NA
$1.1B
-36.44%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Bicara Therapeutics

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Organization
Bicara Therapeutics
Employees
0
CEO
Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
Industry
Miscellaneous

Management People of Bicara Therapeutics

NameTitle
Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
CEO & Director
Mr. Ryan Cohlhepp Pharm.D.
President, COO & Director
Mr. Ivan Hyep M.B.A.
Chief Financial Officer
Ms. Lara S. Meisner J.D.
Chief Legal Officer & Corporate Secretary
Ms. Rachel Salazar
SVP of R&D Strategy and Operations
Ms. Sathish Hasige Ph.D.
Senior VP and Head of Technical Operations & Supply Chain
Dr. David Raben M.D.
Chief Medical Officer
Ms. Angela Windt
VP & Head of Regulatory Affairs
Dr. Jeltje Schulten M.B.A., M.D.
Senior Vice President of Clinical & Medical Affairs
Mr. Jean-Paul Rodrique
Senior VP & Global Head of Quality Assurance

Important FAQs about investing in BCAX Stock from India :

What is Bicara Therapeutics share price today?

Bicara Therapeutics share price today stands at $14.88, Open: $13.80 ; Previous Close: $13.67 ; High: $14.88 ; Low: $12.81 ; 52 Week High: $28.09 ; 52 Week Low: $11.10.

The stock opens at $13.80, after a previous close of $13.67. The stock reached a daily high of $14.88 and a low of $12.81, with a 52-week high of $28.09 and a 52-week low of $11.10.

Can Indians buy Bicara Therapeutics shares?

Yes, Indians can invest in the Bicara Therapeutics (BCAX) from India.

With INDmoney, you can buy Bicara Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bicara Therapeutics at zero transaction cost.

How can I buy Bicara Therapeutics shares from India?

It is very easy to buy Bicara Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bicara Therapeutics (BCAX) be purchased?

Yes, you can buy fractional shares of Bicara Therapeutics with INDmoney app.

What are the documents required to start investing in Bicara Therapeutics stocks?

To start investing in Bicara Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bicara Therapeutics Stock (BCAX)?

Today’s highest price of Bicara Therapeutics (BCAX) is $14.88.

Today’s lowest price of Bicara Therapeutics (BCAX) is $12.81.

What is today's market capitalisation of Bicara Therapeutics?

Today's market capitalisation of Bicara Therapeutics BCAX is 1.1B

What is the 52 Week High and Low Range of Bicara Therapeutics Stock (BCAX)?

  • 52 Week High

    $28.09

  • 52 Week Low

    $11.10

What are the historical returns of Bicara Therapeutics (BCAX)?

  • 1 Month Returns

    21.57%

  • 3 Months Returns

    -36.44%

  • 1 Year Returns

    -36.44%

  • 5 Years Returns

    -36.44%

Who is the Chief Executive Officer (CEO) of Bicara Therapeutics ?

Ms. Claire Mazumdar Clemon M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Bicara Therapeutics.